Enhancement of antinociception by co-administration of ibuprofen and caffeine in arthritic rats

European Journal of Pharmacology

Volumn 544, Issue 1-3, 2006, Pages 31-38

  López, José Raúl Medina ^a   Domínguez Ramírez, Adriana Miriam ^a   Cook, Helgi Jung ^b   Bravo, Guadalupe ^d   Díaz Reval, Ma Irene ^c   Déciga Campos, Myrna ^e   López Muñoz, Francisco Javier ^d  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSIDAD DE COLIMA   (Mexico)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

^e UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

Author keywords

Analgesia; Antinociception; Caffeine; Ibuprofen; PIFIR model; Potentiation

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CAFFEINE; IBUPROFEN; MORPHINE; URIC ACID;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTHRALGIA; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; IBUPROFEN; MALE; RATS; RATS, WISTAR; TIME FACTORS;

EID: 33746639100     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.06.041     Document Type: Article

References (42)

1. Ahijanian M.K., and Takemore A.E. Effect of (-)-N6-(R-Phenylisopropyl)-adenosine (PIA) and caffeine on nociception and morphine-induced analgesia, tolerance and dependence in mice. Eur. J. Pharmacol. 112 (1985) 171-179
2. Berenbaum M.C. A method for testing for synergy with any number of agents. J. Infect. Dis. 137 (1978) 122-130
3. Besson J.M. The neurobiology of pain. Lancet 353 (1999) 1610-1615
4. Beubler E., and Lembeck P. Methylxanthines and intestinal absorption. Naunyn-Schmiedeberg's Arch. Pharmacol. 229 (1976) 73-77
5. Biaggioni I., Paul S., Puckett A., and Arzubiaga C. Caffeine and theophylline as adenosine receptor antagonists in humans. J. Pharmacol. Exp. Ther. 258 (1991) 588-593
6. Castañeda-Hernández G., Castillo-Méndez M.S., López-Muñoz F.J., Granados-Soto V., and Flores-Murrieta F.J. Potentiation by caffeine of the analgesic effect of aspirin in the pain-induced functional impairment model in the rat. Can. J. Physiol. Pharmacol. 72 (1994) 1127-1131
7. Chou T.C., and Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22 (1984) 27-55
8. Contreras E., Germany A., and Villar M. Effects of some adenosine analogs on morphine-induced analgesia and tolerance. Gen. Pharmacol. 21 (1990) 763-767
9. Covino B.G., Dubner R., Gybels J., Kosterlitz H.W., Liebeskind J.C., Sternbach R.A., Vyklicky L., Yamamura H., and Zimmermann M. Ethical standards for investigation of experimental pain in animals. Pain 9 (1980) 141-143
10. Debas H.T., Cohen M.M., Holubitsky I.B., and Harrison R.C. Caffeine stimulated gastric acid and pepsine secretion dose-response studies. Scand. J. Gastroenterol. 6 (1971) 453-457
11. Díaz-Reval M.I., Ventura-Martínez R., Hernández-Delgadillo G.P., Domínguez-Ramírez A.M., and López-Muñoz F.J. Effect of caffeine on antinociceptive action of ketoprofen in rats. Arch. Med. Res. 32 1 (2001) 13-20
12. Engelhardt G., Mauz A.B., and Pairet M. Role of caffeine in combined analgesic drugs from the point of view of experimental pharmacology. Drug Res. 47 (1997) 917-927
13. Fiebich B.L., Lieb K., Hüll M., Aicher B., Van Ryn J., Pairet M., and Engelhardt G. Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on prostaglandin E2 synthesis in rat microglial cells. Neuropharmacol. 39 (2000) 2205-2213
14. Filiap J., Porteix A., Marty H., Eschalier A., and Duchene-Marullaz P. Lack of importance of caffeine as an analgesic adjuvant of dipyrone in mice. Arch. Int. Pharmacodyn. 302 (1989) 86-95
15. Flores-Acevedo D.M., Flores-Murrieta F.J., Castañeda-Hernández G., and López-Muñoz F.J. Potentiation of the analgesic effect of tolmetin, a potent non-steroidal anti-inflammatory drug, by caffeine in the rat. Pharm. Sci. 1 (1995) 441-444
16. Fredholm B.B., Battig K., Holmén J., Nehlig A., and Zvatau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51 (1999) 83-133
17. Forbes J.A., Beaver W.T., Jones K.F., Kehm C.J., Smith W.K., Gongloff C.M., Zeleznock J.R., and Smith J.W. Effect of caffeine on ibuprofen analgesia in postoperative oral surgery pain. Clin. Pharmacol. Ther. 49 (1991) 674-684
18. Gayawali K., Panhi P., and Sharma P.L. Determination of the optimal analgesia-potentiating dose of caffeine and a study of its effects on the pharmacokinetics of aspirin in mice. Methods Find. Exp. Clin. Pharmacol. 13 (1991) 529-533
19. Ghelardine C., Galeotti N., and Bartolini A. Caffeine induces central cholinergic analgesia. Naunyn-Schmiedeberg's Arch. Pharmacol. 356 (1997) 590-595
20. Granados-Soto V., López-Muñoz F.J., Castañeda-Hernández G., Salazar L.A., Villarreal J.E., and Flores-Murrieta F.J. Characterization of the analgesic effects of paracetamol and caffeine combinations in the pain-induced functional impairment model in the rat. J. Pharm. Pharmacol. 45 (1993) 741-744
21. Insel P.A. Analgesic-antipyretics and anti-inflammatory agents: drugs employed in the treatment of rheumatoid arthritis and gout. In: Goodman L.S., Gilman A., Rall T.W., Nies A.S., and Taylor P. (Eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics, Eighth ed (1992), McGraw-Hill International Editions, New York, NY 638-681
22. Iqbal N., Ahmad B., Hussain J.K., Hassan G.A., and Khan N.S. The effect of caffeine on the pharmacokinetics of acetaminophen in man. Biopharm. Drug Dispos. 16 (1995) 481-487
23. Laska E.M., Sunshine A., and Zighelboim I. Effect of caffeine on acetaminophen analgesia. Clin. Pharmacol. Ther. 33 (1983) 498-509
24. Laska E.M., Sunshine A., Muller F., Elvers W.B., Siegel C., and Rubin A. Caffeine as an analgesic adjuvant. JAMA 251 (1984) 1711-1718
25. Loewe S. The problem of synergism and antagonism of combined drugs. Arzneim.-Forsch. 3 (1953) 285-290
26. López-Muñoz F.J. Surface of synergistic interaction between dipyrone and morphine in the PIFIR model. Drug Dev. Res. 33 (1994) 26-32
27. López-Muñoz F.J., Salazar L.A., Castañeda-Hernández G., and Villarreal J.E. A new model to assess analgesic activity: pain-induced functional impairment in the rat (PIFIR). Drug Dev. Res. 28 (1993) 169-175
28. López-Muñoz F.J., Castañeda-Hernández G., Flores-Murrieta F.J., and Granados-Soto V. Effect of caffeine coadministration and nitric oxide synthesis inhibition on the antinociceptive action of ketorolac. Eur. J. Pharmacol. 308 (1996) 275-277
29. López-Muñoz F.J., Ventura R., Díaz M.I., Fernández-Guasti A., Tost D., Cabré F., and Mauleón D. Antinociceptive effects of S(+)-ketoprofen and other analgesic drugs in a rat model of pain induced by uric acid. J. Clin. Pharmacol. 38 (1998) 11S-21S
30. López-Muñoz F.J., Ventura R., Díaz M.I., Hernández G.P., Domínguez A.M., García M.L., Cabré F., and Mauleón D. Analysis of antinociceptive effects of flurbiprofen enantiomers in a rat model of arthritic pain. Methods Find. Exp. Clin. Pharmacol. 22 8 (2000) 641-645
31. López-Muñoz F.J., Díaz-Reval M.I., Terrón J.A., and Déciga-Campos M. Analysis of the analgesic interactions between ketorolac (NSAID) and tramadol (atypical opioid drug) during arthritic nociception in rat. Eur. J. Pharmacol. 484 (2004) 157-165
32. Malec D., and Michalska E. The effect of methylxanthines on morphine analgesia in mice and rats. Pol. J. Pharmacol. Pharm. 40 (1988) 223-232
33. Moertel C.G., Ahmann D.L., Taylor W.F., and Schwartau N. Relief of pain by oral medications, a controlled evaluation of analgesic combinations. JAMA 229 (1974) 55-59
34. Nehlig A., Daval J.L., and Debry G. Caffeine and the central nervous system: mechanisms of action biochemical, metabolic and psychostimulant effects. Brain Res. Rev. 17 (1992) 139-170
35. Onrot J., Shaheen O., Biaggioni I., Goldberg M.R., Feely J., Wilkinson G.R., Hollister A.S., and Robertson D. Reduction of liver plasma flow by caffeine and theophylline. Clin. Pharmacol. Ther. 40 (1986) 506-510
36. Rall T.W. Drugs used in the treatment of asthma. The methylxanthines, cromolyn sodium, and other agents. In: Goodman L.S., Gilman A., Rall T.W., Nies A.S., and Taylor P. (Eds). Goodman and Gilman's the Pharmacological Basis of Therapeutics. 8th ed. (1992), Mc Graw-Hill International Editions, New York, NY 618-637
37. Rowland M., Tozer T.N., 1989. Clinical pharmacokinetics: concepts and applications. 2nd ed., Lea & Febiger, Philadelphia, pp 255-275, 459-463.
38. Sawynok J., and Yaksh T.L. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol. Rev. 45 (1993) 43-85
39. Seegers A.J.M., Jager L.P., Zandberg P., and Van Noordwijk J. The antiinflammatory, analgesic and antipyretic activities of non-narcotic analgesic drug mixtures in rats. Arch. Int. Pharmacodyn. Ther. 251 (1981) 237-254
40. Siegers C.P. Effects of caffeine on the absorption and analgesic efficacy of paracetamol in rats. Pharmacology 10 (1973) 19-27
41. Vinegar R., Truax J.F., Selph J.L., Welch R.M., and White H.L. Potentiation of the antiinflammatory and analgesic activity of aspirin by caffeine in the rat. Proc. Soc. Exp. Biol. Med. 151 (1976) 556-560
42. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110